A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

NCT07113392 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

144

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

DRUG: Suraxavir Marboxil
DRUG: Oseltamivir

Sponsor

Jiangxi Kvvit Pharmaceutical Co., Ltd.